Raia Drogasil S.A. Statistics
Raia Drogasil S.A. (RADL3) Stock Statistics & Valuation Metrics
Total Valuation
Raia Drogasil S.A. has a market cap or net worth of BRL 25.48B. The enterprise value is BRL 40.47B.
- Market Cap
- BRL 25.48B
- Enterprise Value
- BRL 40.47B
Share Statistics
Raia Drogasil S.A. has 1,752,367,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,752,367,300
- Owned by Insiders
- ―
- Owned by Institutions
- 26.75%
Financial Efficiency
Raia Drogasil S.A.’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 14.09%.
- Return on Equity (ROE)
- 0.18
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 14.09%
- Return on Capital Employed (ROCE)
- 0.17
- Revenue Per Employee
- 571.50K
- Profits Per Employee
- 16.75K
- Employee Count
- 77,428
- Asset Turnover
- 1.74
- Inventory Turnover
- 3.48
Valuation Ratios
The current PE Ratio of Raia Drogasil S.A. is 19.86. Raia Drogasil S.A.’s PEG ratio is -2.65.
- PE Ratio
- 19.86
- PS Ratio
- 0.57
- PB Ratio
- 3.39
- Price to FCF
- 20.46
- Price to Operating Cash Flow
- 9.55
- PEG Ratio
- -2.65
Income Statement
In the last 12 months, Raia Drogasil S.A. had revenue of 44.25B and earned 1.30B in profits. Earnings per share was 0.79.
- Revenue
- 44.25B
- Gross Profit
- 10.95B
- Operating Income
- 2.64B
- Pretax Income
- 1.45B
- Net Income
- 1.30B
- EBITDA
- 4.65B
- Earnings Per Share (EPS)
- 0.79
Cash Flow
In the last 12 months, operating cash flow was 2.68B and capital expenditures -1.43B, giving a free cash flow of 1.25B billion.
- Operating Cash Flow
- 2.68B
- Free Cash Flow
- 1.25B
- Free Cash Flow per Share
- 0.71
Dividends & Yields
Raia Drogasil S.A. pays an annual dividend of ―, resulting in a dividend yield of 3.08%
- Dividend Per Share
- ―
- Dividend Yield
- 3.08%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.89%
- Earnings Yield
- 5.08%
Stock Price Statistics
- Beta
- 1.22
- 52-Week Price Change
- -34.83%
- 50-Day Moving Average
- 19.08
- 200-Day Moving Average
- 20.25
- Relative Strength Index (RSI)
- 29.13
- Average Volume (3m)
- 12.44M
Important Dates
Raia Drogasil S.A. upcoming earnings date is Mar 09, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Mar 09, 2027
- Ex-Dividend Date
- ―
Financial Position
Raia Drogasil S.A. as a current ratio of 1.46, with Debt / Equity ratio of 120.65%
- Current Ratio
- 1.46
- Quick Ratio
- 0.52
- Debt to Market Cap
- 0.10
- Net Debt to EBITDA
- 1.79
- Interest Coverage Ratio
- 2.46
Taxes
In the past 12 months, Raia Drogasil S.A. has paid 147.81M in taxes.
- Income Tax
- 147.81M
- Effective Tax Rate
- 0.10
Enterprise Valuation
Raia Drogasil S.A. EV to EBITDA ratio is 6.85, with an EV/FCF ratio of 27.21.
- EV to Sales
- 0.75
- EV to EBITDA
- 6.85
- EV to Free Cash Flow
- 27.21
- EV to Operating Cash Flow
- 12.71
Balance Sheet
Raia Drogasil S.A. has BRL 627.20M in cash and marketable securities with BRL 5.89B in debt, giving a net cash position of -BRL 5.26B billion.
- Cash & Marketable Securities
- BRL 627.20M
- Total Debt
- BRL 5.89B
- Net Cash
- -BRL 5.26B
- Net Cash Per Share
- -BRL 3.00
- Tangible Book Value Per Share
- BRL 3.13
Margins
Gross margin is 28.42%, with operating margin of 6.66%, and net profit margin of 2.87%.
- Gross Margin
- 28.42%
- Operating Margin
- 6.66%
- Pretax Margin
- 3.24%
- Net Profit Margin
- 2.87%
- EBITDA Margin
- 11.00%
- EBIT Margin
- 6.16%
Analyst Forecast
The average price target for Raia Drogasil S.A. is BRL 20.50, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- BRL 20.50
- Price Target Upside
- 40.12% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 2
- Revenue Growth Forecast
- 6.87%
- EPS Growth Forecast
- -3.22%
